---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

WeightWatchers

🌎 weightwatchers.com

WeightWatchers is the global leader in science-backed weight management, providing an accessible, holistic model of care through their doctor-recommended Points Program, clinical interventions, and community support. Since 1963, they have empowered millions of members to build healthy habits for longer lives, offering a spectrum of solutions to help members reach and sustain their health goals.

---

WeightWatchers - Latest News and Updates

• WeightWatchers' Chief Nutrition Officer, Dr. Michelle, announced exciting news about GLP-1 medications on May 5.
• WeightWatchers announced the use of FDA-approved medication liraglutide to help manage weight loss and type 2 diabetes.
• WeightWatchers has launched a new range of smart scales in the UK, powered by TANITA, to help users track various health metrics beyond just weight.
• WeightWatchers has integrated with Gifthealth to streamline access to Zepbound® vials for clinic members, offering real-time prescription tracking and simplified fulfillment through the WeightWatchers App.
• Traders are betting on WeightWatchers' stock price climbing above $0.50 by May 16, 2025, as indicated by the high volume of call options.

• WeightWatchers is offering a 60% discount on monthly memberships for 12 months to new or rejoining members, including access to coach-led workshops and personalized nutrition plans.
• WeightWatchers is reopening its weekly workshops in Yankton at First United Methodist Church on May 15, 2025.
• WeightWatchers is currently hiring for the position of Head of Performance Campaigns in the United Arab Emirates.
• WeightWatchers Kenya is hosting a fitness bootcamp at the Arboretum on June 2.
• WeightWatchers found that nearly half of their clinic patients on GLP-1 medications reduced alcohol consumption to minimize GI side effects.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.